OpenDNA Expands Access to Personalized Genomic Health Insights with New Direct-to-Consumer Website
New OpenDNA website enables consumers to explore genomic health testing and order products directly, expanding access
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
New OpenDNA website enables consumers to explore genomic health testing and order products directly, expanding access beyond clinics and healthcare providers
CLARKSBURG, MD, UNITED STATES, October 5, 2026 /EINPresswire.com/ — OpenDNA, a genomic precision medicine company combining genomics, artificial intelligence, and clinical data, today announced the launch of its new direct-to-consumer website, opendnahealth.com, providing consumers with a new way to access personalized genomic health information. Genomic testing includes polygenic risk scores (PRS) for cardiometabolic diseases, namely, coronary heart disease, obesity, type 2 diabetes, high cholesterol, and hypertension.
OpenDNA’s genomic testing products are already offered through multiple healthcare providers across the United States, including concierge medicine and primary care practices. With the launch of opendnahealth.com, consumers can now visit the website, learn about OpenDNA’s products and technology, and order a direct-to-consumer genomic health product directly online.
The new consumer offering focuses on helping individuals better understand their genetic predisposition to important cardiometabolic diseases and provides personalized insights designed to help them have more informed conversations about their health and potential next steps.
The consumer experience combines genomic analysis with OpenDNA’s AI-powered technology to translate complex genetic information into a clear, personalized prevention plan. Consumers also have access to a telemedicine consultation with a physician to discuss their results and personalized prevention plan.
“Genomic testing is becoming increasingly accessible, but consumers need more than a test result,” said Eran Feldhay, MD, founder and CEO of OpenDNA. “Our goal is to make personalized genomic health information easier to access, easier to understand, and more actionable. With opendnahealth.com, consumers can explore our technology and order directly, while still having access to professional guidance.”
Visit opendnahealth.com
The new website provides consumers with information about OpenDNA’s technology, its genomic health products, and the company’s approach to combining genomics, AI, and clinical information.
Consumers can visit opendnahealth.com to explore the offering and order directly online.
Know your risk. Understand your results. Talk to a doctor. Take action.
About OpenDNA
OpenDNA is a genomic precision medicine company combining genomics, artificial intelligence, and clinical data to provide personalized insights into disease risk. The company offers both clinical products through healthcare providers and direct-to-consumer products through its online platform.
OpenDNA’s technology is designed to help individuals and healthcare providers better understand genetic risk and support more personalized approaches to health and disease prevention.
For more information, visit opendnahealth.com
Media Contact:
Nir Gamliel
OpenDNA
+1 240-401-9712
nir@open-dna.com
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
